跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
盧 晞卉
Doctor
影像醫學部
電子郵件
n049780
mail.hosp.ncku.edu
tw
h-index
21
引文
3
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2017
2025
每年研究成果
概覽
指紋
網路
研究成果
(8)
類似的個人檔案
(6)
指紋
查看啟用 Hsi-Huei Lu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Overall Survival
60%
Invasive Lobular Carcinoma
50%
National Cohort Study
50%
Colon Metastasis
50%
Breast Carcinoma
50%
Adjuvant Chemotherapy
50%
Radiation-induced Hypothyroidism
50%
Prognostic Significance
50%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
50%
Esophageal Cancer
50%
Dual Time Point
50%
Chemotherapy
50%
Prostate-specific Antigen Doubling Time
50%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
50%
Definitive Concurrent Chemoradiotherapy
50%
Radium
50%
Confidence Interval
45%
Hazard Ratio
45%
Risk of Death
42%
Low Risk
36%
Normal Tissue Complication Probability Models
33%
Chest Wall Tumor
33%
Combined Modality Therapy
25%
Distant Metastasis
25%
Mortality Hazard
22%
Age-stage
20%
Histology
20%
Tumor Location
20%
Nasopharyngeal Carcinoma
18%
Developmental Validation
16%
Benign Vascular Tumor
16%
Taiwan Cancer Registry
16%
Para-aortic Lymph Node
12%
Modified Radical Mastectomy
12%
Subepithelial Tumor
12%
Contralateral Breast
12%
Invasive Lobular Breast Cancer
12%
Cytokeratin
12%
Metastatic Cancer
12%
Breast Mass
12%
Metastasizing
12%
Colonoscopy
12%
Hormone Therapy
12%
Stool
12%
Primary Colon Cancer
12%
Gastrointestinal Tract
12%
Occult Blood
12%
Clinical Experience
12%
Caudal Type Homeobox 2
12%
Colon
12%
Medicine and Dentistry
Chemoradiotherapy
100%
Fluorodeoxyglucose F 18
100%
Overall Survival
68%
Radiation Therapy
63%
Metastatic Colon Cancer
50%
Esophageal Cancer
50%
Adjuvant Chemotherapy
50%
Hypothyroidism
50%
Positron Emission Tomography-Computed Tomography
50%
Polyethylene Terephthalate
50%
Head and Neck Cancer
50%
Nasopharynx Cancer
50%
Mouth Squamous Cell Carcinoma
50%
Lobular Carcinoma
50%
Radium Therapy
50%
Hazard Ratio
48%
Distant Metastasis
40%
Nasopharynx Carcinoma
40%
Thorax Wall Tumor
33%
Diseases
28%
Colon
25%
Oral Cancer
21%
Cancer Registry
21%
Prognostic Factor
20%
Hormone Therapy
12%
Cytokeratin
12%
Blood Screening
12%
Contralateral
12%
Synapsin II
12%
Modified Radical Mastectomy
12%
Adrenal Gland
12%
Gastrointestinal Bleeding
12%
Paraaortic Lymph Node
12%
Metastatic Breast Cancer
12%
Colonoscopy
12%
Protein Binding
12%
Gastrointestinal Tract
12%
Homeobox
12%
Breast Tumor
12%
Propensity Score Matching
10%
Neoadjuvant Chemotherapy
10%
Fluorouracil
10%
Distant Metastasis Free Survival
10%
Disease Free Survival
10%
Proportional Hazards Model
10%
Late Effect
8%
Neoplasm
8%
Survival Rate
7%
Retrospective Study
7%
